BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024
BrainsWay (NASDAQ & TASE: BWAY), a global leader in noninvasive neurostimulation treatments for mental health disorders, has scheduled its third quarter 2024 financial results announcement for November 12, 2024, before U.S. markets open. The company will host a conference call and webcast at 8:30 AM Eastern Time to discuss results and provide business updates. The call will be accessible via multiple dial-in numbers and will be available for replay on the company's website for 30 days.
BrainsWay (NASDAQ & TASE: BWAY), un leader globale nel trattamento non invasivo di neurostimolazione per disturbi mentali, ha programmato l'annuncio dei suoi risultati finanziari del terzo trimestre 2024 per il 12 novembre 2024, prima dell'apertura dei mercati statunitensi. L'azienda ospiterà una conferenza telefonica e una diretta web alle 8:30 ora dell'Est per discutere i risultati e fornire aggiornamenti aziendali. La chiamata sarà accessibile tramite diversi numeri di accesso e sarà disponibile per la riproduzione sul sito web dell'azienda per 30 giorni.
BrainsWay (NASDAQ & TASE: BWAY), un líder mundial en tratamientos de neuroestimulación no invasivos para trastornos de salud mental, ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 para el 12 de noviembre de 2024, antes de la apertura de los mercados en EE. UU. La empresa llevará a cabo una llamada y una transmisión web a las 8:30 AM hora del Este para discutir los resultados y proporcionar actualizaciones sobre el negocio. La llamada será accesible a través de varios números de acceso y estará disponible para su repetición en el sitio web de la empresa durante 30 días.
BrainsWay (NASDAQ & TASE: BWAY), 정신 건강 장애를 위한 비침습적 신경 자극 치료의 글로벌 리더, 2024년 3분기 재무 결과 발표를 2024년 11월 12일 미국 시장 개장 전에 예정하였습니다. 회사는 결과를 논의하고 비즈니스 업데이트를 제공하기 위해 동부 표준시 기준 오전 8시 30분에 컨퍼런스 콜과 웹캐스트를 개최할 것입니다. 이 통화는 여러 다이얼인 번호를 통해 접근 가능하며 회사 웹사이트에서 30일 동안 재생할 수 있습니다.
BrainsWay (NASDAQ & TASE: BWAY), un leader mondial dans les traitements de neurostimulation non invasifs pour les troubles de la santé mentale, a prévu l'annonce de ses résultats financiers du troisième trimestre 2024 pour le 12 novembre 2024, avant l'ouverture des marchés américains. L'entreprise organisera une conférence téléphonique et un webinaire à 8h30, heure de l'Est, pour discuter des résultats et fournir des mises à jour sur l'entreprise. L'appel sera accessible via plusieurs numéros de connexion et sera disponible en rediffusion sur le site Web de l'entreprise pendant 30 jours.
BrainsWay (NASDAQ & TASE: BWAY), ein globaler Marktführer für nicht-invasive Neurostimulationsbehandlungen bei psychischen Erkrankungen, hat die Bekanntgabe seiner Finanzergebnisse für das dritte Quartal 2024 für den 12. November 2024, vor der Eröffnung der US-Märkte, angesetzt. Das Unternehmen wird eine Telefonkonferenz und ein Webcast um 8:30 Uhr Eastern Time veranstalten, um die Ergebnisse zu besprechen und geschäftliche Updates zu geben. Die Sitzung wird über verschiedene Einwahlnummern zugänglich sein und für 30 Tage auf der Unternehmenswebsite als Wiederholung zur Verfügung stehen.
- None.
- None.
BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its third quarter 2024 financial results as well as operational highlights before the open of the U.S. financial markets on Tuesday, November 12, 2024. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.
Conference Call Dial-In & Webcast Information
| Date: | Tuesday, November 12, 2024 |
| Time: | 8:30 AM Eastern Time |
| United States: | 1-877-300-8521 |
| International: | 1-412-317-6026 |
| Israel: | 1-80-921-2373 |
| Conference ID: | 10193781 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1693565&tp_key=866e8470ea |
The conference call will be broadcast live and will be available for replay for 30 days on the Company’s website, https://investors.brainsway.com/events-and-presentations/event-calendar. Please access the Company’s website at least 10 minutes ahead of the conference call to register.
About BrainsWay
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with offices in Burlington, MA and Jerusalem, Israel, BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com.
Contacts:
BrainsWay:
Ido Marom
Chief Financial Officer
Ido.Marom@BrainsWay.com
Investors:
Brian Ritchie
LifeSci Advisors
britchie@lifesciadvisors.com
FAQ
When will BrainsWay (BWAY) release Q3 2024 earnings?
What time is BrainsWay's (BWAY) Q3 2024 earnings call?
How can I access BrainsWay's (BWAY) Q3 2024 earnings call?
